| Literature DB >> 28490749 |
Ruofei Jin1, Yao Liu1, Guangfei Liu2, Tian Tian1, Sen Qiao1, Jiti Zhou1.
Abstract
Bioremediation of Cr(VI) and nitrate is considered as a promising and cost-effective alternative to chemical and physical methods. However, organo-Cr(III) complexes in effluent generally causes environmental concerns due to second-pollution. Here, Cr(VI) reduction and immobilization efficiencies of anaerobic activated sludge were investigated. Anaerobic activated sludge showed strong reduction ability of Cr(VI) and possessed a great potential of Cr(III) immobilization. Almost 100.0 mg l-1 Cr(VI) could be completely reduced and immobilized by anaerobic activated sludge in a sequencing batch reactor in 24 h. And most generated Cr(III) was accumulated outside of sludge cells. Extracellular polymeric substances (EPS) could bind to Cr(VI) and form EPS-Cr(VI) interaction to reduce the toxic effect of Cr(VI) and promote the Cr(VI) reduction. Protein-like and humic-like substances were responsible for binding with Cr(VI), meanwhile the process was a thermodynamically favorable binding reaction. Then Cr(VI) was reduced to Cr(III) by membrane-associated chromate reductase of sludge. Eventually, the generated Cr(III) might exist as poly-nuclear Cr(III) complexes adhered to sludge surfaces.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28490749 PMCID: PMC5431812 DOI: 10.1038/s41598-017-01885-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Effect of Cr(VI) on the CODCr, NO3-N, NO2-N and Cr(VI) removal in the anaerobic reactor. Variations of (a) CODCr, (b) NO3-N, (c) NO2-N and (d) Cr concentrations in the influent and effluent under different Cr(VI) concentrations. The Cr(VI) concentrations were 0.0, 2.5, 5.0, 10.0, 15.0, 20.0, 30.0, 50.0, 80.0 and 120.0 mg l−1, corresponding to the phase 0, 1, 2, 3, 4, 5, 6, 7, 8, and 9, respectively.
Figure 2Morphology and element analyses. (a) SEM of the activated sludge without Cr(VI); (b) SEM of the activated sludge with Cr(VI); (c) EDS for the sludge with Cr(VI); (d) TEM of the activated sludge without Cr(VI); (e) TEM of the activated sludge with Cr(VI); (f) and (g) EDS for the TEM outside and inside of cell with Cr(VI), respectively. Samples were taken at Day 10 and Day 130.
Partitions of Cr(VI) and Cr(III) in the activated sludge compartments after 15 days of incubation. Concentrations of Cr(VI) and Cr(III) are expressed on a dry mass basis of activated sludge. *Represent standard deviation (s.d.).
| Total Cr(VI) (mg g−1) | Cr(VI) and Cr(III) concentrations in compartments (mg g−1) | |||||
|---|---|---|---|---|---|---|
| Adsorbed | Intercellular | Intracellular | ||||
| Cr(III) | Cr(VI) | Cr(III) | Cr(VI) | Cr(III) | Cr(VI) | |
| 4.32 ± 0.220* | 0.0501 ± 0.002 | 0.0065 ± 0.001 | 3.356 ± 0.145 | 0.160 ± 0.030 | 0.418 ± 0.018 | 0.127 ± 0.028 |
| 8.72 ± 0.330 | 0.0714 ± 0.002 | 0.0122 ± 0.003 | 6.831 ± 0.234 | 0.175 ± 0.067 | 0.401 ± 0.038 | 0.435 ± 0.045 |
| 25.78 ± 3.670 | 0.122 ± 0.039 | 0.0188 ± 0.004 | 20.156 ± 3.458 | 0.435 ± 0.047 | 0.523 ± 0.063 | 0.522 ± 0.057 |
The Cr(VI) reducing capability of activated sludge, activated sludge without EPS, EPS and nutrient. *Represent standard deviation (s.d.).
| Time (h) | Concentrations of Cr(VI) (mg l−1) | |||
|---|---|---|---|---|
| Activated sludge | Activated sludge without EPS | EPS | Nutrient | |
| 0 | 100.05 ± 1.94* | 100.12 ± 1.95 | 100.40 ± 2.35 | 100.60 ± 2.09 |
| 4 | 72.62 ± 1.29 | 75.15 ± 2.04 | 98.97 ± 1.56 | 99.34 ± 0.98 |
| 8 | 45.53 ± 1.12 | 55.76 ± 1.57 | 96.28 ± 1.69 | 98.24 ± 1.06 |
| 12 | 30.88 ± 1.34 | 40.25 ± 1.85 | 94.29 ± 2.12 | 97.68 ± 1.23 |
| 16 | 10.74 ± 0.89 | 32.63 ± 1.03 | 93.47 ± 1.67 | 97.57 ± 1.78 |
| 24 | 1.05 ± 0.12 | 30.63 ± 1.47 | 92.63 ± 2.34 | 97.55 ± 1.45 |
The Cr(VI) reducing capability of sludge after heating denaturalization and protein denaturant treatments (25 °C). *Represents standard deviation (s.d.).
| Time (h) | Concentrations of Cr(VI) (mg l−1) | |||||
|---|---|---|---|---|---|---|
| Control | 5 mM Hg2+ | 10 mM Ag+ | 0.5% SDS | 60 °C | 90 °C | |
| 0 | 99.50 ± 2.05* | 100.78 ± 1.49 | 100.30 ± 1.60 | 100.05 ± 2.20 | 99.60 ± 1.83 | 99.80 ± 1.83 |
| 6 | 46.65 ± 1.43 | 98.06 ± 1.94 | 97.84 ± 2.34 | 96.26 ± 1.98 | 75.16 ± 1.60 | 94.63 ± 2.14 |
| 12 | 6.60 ± 1.33 | 97.54 ± 2.14 | 97.05 ± 1.98 | 95.49 ± 1.08 | 74.64 ± 1.50 | 94.09 ± 1.14 |
Figure 3UV-visible spectra analysis. (a) Differentiated spectra of EPS, Cr(VI) and the mixture of EPS and Cr(VI) at various Cr(VI) dosages; (b) differentiated spectra of EPS, Cr(III) and the mixture of EPS and Cr(III) at various Cr(III) dosages.
Figure 4EEM spectra of two main fluorescence components obtained from PARAFAC analysis. (a) proteins-like substances; (b) humic-like substances; (c) their peak intensities of the EEM spectra at various Cr6+ dosages obtained from PARAFAC analysis.
Complexation parameters of Cr with the EPS.
| Sample | Cr | Peaks | ksv (×104) | R2 |
|---|---|---|---|---|
| EPS | Cr(VI) | P | 2.817 | 0.9594 |
| H | 0.125 | 0.9538 | ||
| Cr(III) | P | 0.071 | 0.9283 | |
| H | 0.028 | 0.9943 |
Figure 5Calorimetric titration of Cr(VI) with EPS in Tris-HCl buffer at 298.15 K. (a) Heat released per injection of Cr(VI) in the ITC experiments; (b) non-linear regression of the heat vs Cr(VI) dosage.
Figure 6A schematic diagram of Cr(VI) reduction by anaerobic activated sludge.